Literature DB >> 2957435

Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement.

W M Padberg, R H Lord, J W Kupiec-Weglinski, J M Williams, R Di Stefano, L E Thornburg, D Araneda, T B Strom, N L Tilney.   

Abstract

The events leading to immunologic enhancement in LEW rats immunized actively with Brown Norway (BN) rat spleen cells and passively with LEW anti-BN hyperimmune serum 11 and 10 days before receiving (LEW X BN)F1 cardiac allografts, respectively, have been studied. Cellular suppressor mechanisms developing during the induction phase of this phenomenon have recently been shown to be mediated by W3/25+ T cells in an antigen-specific manner. The present study suggests that the late maintenance phase of immunologic enhancement is mediated in vivo by simultaneously present separate donor-specific T cell subpopulations of W3/25+ and OX8+ phenotypes. Splenocyte subsets from grafted recipients greater than 100 days after transplantation were adoptively transferred into unmodified syngeneic LEW rats that received a specific test allograft 24 hr later, or into B recipients bearing indefinitely surviving heart grafts. Test graft survival was prolonged significantly in the first group and not altered in the second. Indeed, nonoverlapping W3/25+ and OX8+ cell fractions were separately responsible for suppression. However, when suppressor activity was tested in vitro in a three-component coculture mixed lymphocyte reaction, no suppression by T cells was obtained; this lack of correlation between in vivo and in vitro results has also been noted by other investigators in different systems. Thus, in the maintenance phase of actively and passively induced immunologic enhancement, interplay between two phenotypically distinct T cells with suppressor characteristics, but not putative cell-surface blocking factors, seems to prevent development of an alloreactive response and mediate host unresponsiveness.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957435

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.

Authors:  Qizhi Tang; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Mol Cell Biol       Date:  2011-12-14       Impact factor: 6.216

2.  Immunological tolerance induced by liver grafting in the rat: splenic macrophages and T cells mediate distinct phases of immunosuppressive activity.

Authors:  S Yoshimura; S Gotoh; N Kamada
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Mechanisms in passive enhancement of cardiac and renal allografts by serum from liver-grafted rats.

Authors:  A Yamaguchi; N Kamada
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

Review 4.  The biology of acute transplant rejection.

Authors:  N L Tilney; J W Kupiec-Weglinski
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

5.  Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action.

Authors:  B M Hall; N W Pearce; K E Gurley; S E Dorsch
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

6.  The Potential of IgG to Induce Murine and Human Thymic Maturation of IL-10+ B Cells (B10) Revealed in a Pilot Study.

Authors:  Amanda Harumi Sabô Inoue; Aline Aparecida de Lima Lira; Marília Garcia de-Oliveira; Thamires Rodrigues de Sousa; Fábio da Ressureição Sgnotto; Alberto José da Silva Duarte; Jefferson Russo Victor
Journal:  Cells       Date:  2020-10-05       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.